Cargando…

Efficacy of Stiripentol in Dravet Syndrome with or without SCN1A Mutations

BACKGROUND AND PURPOSE: The aim of this study was to determine the effectiveness of stiripentol (STP) add-on therapy to valproate and clobazam in patients with Dravet syndrome (DS) according to the presence of mutations in the sodium channel alpha-1 subunit gene (SCN1A). METHODS: We performed direct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Min Jung, Kwon, Soon Sung, Ko, Ara, Lee, Seung-Tae, Lee, Young Mock, Kim, Heung Dong, Chung, Hee Jung, Kim, Se Hee, Lee, Joon Soo, Kim, Dae-Sung, Kang, Hoon-Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765252/ https://www.ncbi.nlm.nih.gov/pubmed/29141279 http://dx.doi.org/10.3988/jcn.2018.14.1.22

Ejemplares similares

Stiripentol for Dravet syndrome
Publicado: (2020)

Audit of use of stiripentol in adults with Dravet syndrome
por: Balestrini, S., et al.
Publicado: (2016)

The Role of Focal Epilepsy Features in Defining SCN1A Mutation-positive Dravet Syndrome as Generalized and Focal Epilepsy
por: Ko, Young Jun, et al.
Publicado: (2021)

Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea
por: Koo, Chung Mo, et al.
Publicado: (2020)

Efficient strategy for the molecular diagnosis of intractable early-onset epilepsy using targeted gene sequencing
por: Rim, John Hoon, et al.
Publicado: (2018)

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial
por: Nabbout, Rima, et al.
Publicado: (2020)

Adverse Events During Perampanel Adjunctive Therapy in Intractable Epilepsy
por: Youn, Song Ee, et al.
Publicado: (2018)

Analysis of trio test in neurodevelopmental disorders
por: Kim, Se Hee, et al.
Publicado: (2022)

Epilepsy in Korean patients with Angelman syndrome
por: Park, Sung-Hee, et al.
Publicado: (2012)

Dravet syndrome: a new causative SCN1A mutation?
por: Poryo, Martin, et al.
Publicado: (2017)

Drug repurposing for Dravet syndrome in scn1Lab (−/−) mutant zebrafish
por: Sourbron, Jo, et al.
Publicado: (2019)

Ictal vocalizations in the Scn1a (+/−) mouse model of Dravet syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2023)

The Efficacy of Ketogenic Diet for Specific Genetic Mutation in Developmental and Epileptic Encephalopathy
por: Ko, Ara, et al.
Publicado: (2018)

Delayed maturation of GABAergic signaling in the Scn1a and Scn1b mouse models of Dravet Syndrome
por: Yuan, Yukun, et al.
Publicado: (2019)

Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome
por: Lenk, Guy M., et al.
Publicado: (2020)

Antiepileptic Stiripentol May Influence Bones
por: Matuszewska, Agnieszka, et al.
Publicado: (2021)

Therapeutic effects of stiripentol against ischemia-reperfusion injury in gerbils focusing on cognitive deficit, neuronal death, astrocyte damage and blood brain barrier leakage in the hippocampus
por: Shin, Myoung Cheol, et al.
Publicado: (2022)

SCN1B and SCN2B gene variants analysis in dravet syndrome patients: Analysis of 22 cases
por: Gong, Jiao-E., et al.
Publicado: (2019)

Dravet Syndrome in Lebanon: First Report on Cases with SCN1A Mutations
por: Alame, Saada, et al.
Publicado: (2019)

Augmented Reticular Thalamic Bursting and Seizures in Scn1a-Dravet Syndrome
por: Ritter-Makinson, Stefanie, et al.
Publicado: (2019)

Augmented Reticular Thalamic Bursting and Seizures in Scn1a-Dravet Syndrome
por: Ritter-Makinson, Stefanie, et al.
Publicado: (2019)

TANGO With SCN1A: Can This Molecular Dance Defeat Dravet Syndrome?
por: Wagnon, Jacy L.
Publicado: (2020)

Is stiripentol truly effective for treating primary hyperoxaluria?
por: Martin-Higueras, Cristina, et al.
Publicado: (2020)

Commentary: Targeting LDH enzymes with a stiripentol analog to treat epilepsy
por: Cho, Chang-Hoon
Publicado: (2015)

Identification of SCN1A and PCDH19 Mutations in Chinese Children with Dravet Syndrome
por: Kwong, Anna Ka-Yee, et al.
Publicado: (2012)

Morphometry and network-based atrophy patterns in SCN1A-related Dravet syndrome
por: Lenge, Matteo, et al.
Publicado: (2023)

Electroencephalography characteristics related to risk of sudden unexpected death in epilepsy in patients with Dravet syndrome
por: Kim, Jeong-Youn, et al.
Publicado: (2023)

Large-scale structural alteration of brain in epileptic children with SCN1A mutation
por: Lee, Yun-Jeong, et al.
Publicado: (2017)

SCN1A Gene Mutation and Adaptive Functioning in 18 Vietnamese Children with Dravet Syndrome
por: Do, Thi Thu Hang, et al.
Publicado: (2017)

Behavioral Comorbidities and Drug Treatments in a Zebrafish scn1lab Model of Dravet Syndrome
por: Grone, Brian P., et al.
Publicado: (2017)

SCN1A Mutation—Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis
por: Ding, Jiangwei, et al.
Publicado: (2021)

Clinical Features and Treatment Outcomes of Seronegative Pediatric Autoimmune Encephalitis
por: Lee, Sangbo, et al.
Publicado: (2021)

Angiolipoma of the stomach presenting with anaemia
por: Nam, Yang Hoon, et al.
Publicado: (2014)

SCN1A Genetic Test for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy and its Clinical Subtypes) for use in the Diagnosis, Prognosis, Treatment and Management of Dravet Syndrome
por: Stenhouse, Susan A.R., et al.
Publicado: (2013)

Efficacy of the Ketogenic Diet for Pediatric Epilepsy According to the Presence of Detectable Somatic mTOR Pathway Mutations in the Brain
por: Ko, Ara, et al.
Publicado: (2022)

EC-18, a Synthetic Monoacetyldiacylglyceride, Inhibits Hematogenous Metastasis of KIGB-5 Biliary Cancer Cell in Hamster Model
por: Kim, Myung-Hwan, et al.
Publicado: (2009)

Optimized Treatment for Infantile Spasms: Vigabatrin versus Prednisolone versus Combination Therapy
por: Hahn, Jongsung, et al.
Publicado: (2019)

Electrocardiography as an early cardiac screening test in children with mitochondrial disease
por: Baik, Ran, et al.
Publicado: (2010)

Genetic Variation of SCN5A in Korean Patients with Sick Sinus Syndrome
por: Lee, Young Soo, et al.
Publicado: (2016)

Amyotrophic Lateral Sclerosis - Cell Based Therapy and Novel Therapeutic Development
por: Kim, Changsung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f6cigsferji831pvp9tlelb21k